2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide

C23H20Cl2N2O5S — CID 69283020

IUPAC2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide
SMILESO=C(Cc1ccc(Cl)cc1)Nc1ccc2c(c1)N(S(=O)(=O)c1ccc(Cl)cc1)C[C@@H](CO)O2
InChIInChI=1S/C23H20Cl2N2O5S/c24-16-3-1-15(2-4-16)11-23(29)26-18-7-10-22-21(12-18)27(13-19(14-28)32-22)33(30,31)20-8-5-17(25)6-9-20/h1-10,12,19,28H,11,13-14H2,(H,26,29)/t19-/m0/s1
InChIKeyFMVHKUDWOXFOQW-IBGZPJMESA-N
MW507.40 g/mol
LogP4.12
Rot. Bonds6

About 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide

2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide (PubChem CID 69283020) has the molecular formula C23H20Cl2N2O5S and a molecular weight of 507.40 g/mol. Its IUPAC name is 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide.

Molecular Properties

Compound Name2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide
PubChem CID69283020
Molecular FormulaC23H20Cl2N2O5S
Molecular Weight507.40 g/mol
Exact Mass506.05
IUPAC Name2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide
SMILESO=C(Cc1ccc(Cl)cc1)Nc1ccc2c(c1)N(S(=O)(=O)c1ccc(Cl)cc1)C[C@@H](CO)O2
InChIInChI=1S/C23H20Cl2N2O5S/c24-16-3-1-15(2-4-16)11-23(29)26-18-7-10-22-21(12-18)27(13-19(14-28)32-22)33(30,31)20-8-5-17(25)6-9-20/h1-10,12,19,28H,11,13-14H2,(H,26,29)/t19-/m0/s1
InChIKeyFMVHKUDWOXFOQW-IBGZPJMESA-N
XLogP4.12
TPSA95.94 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500507.40
LogP ≤ 54.12
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide?
The IUPAC name of 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide (CID 69283020) is 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide.
What is the SMILES notation for 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide?
The canonical SMILES for 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide is O=C(Cc1ccc(Cl)cc1)Nc1ccc2c(c1)N(S(=O)(=O)c1ccc(Cl)cc1)C[C@@H](CO)O2.
What is the InChIKey of 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide?
The InChIKey is FMVHKUDWOXFOQW-IBGZPJMESA-N. The full InChI is InChI=1S/C23H20Cl2N2O5S/c24-16-3-1-15(2-4-16)11-23(29)26-18-7-10-22-21(12-18)27(13-19(14-28)32-22)33(30,31)20-8-5-17(25)6-9-20/h1-10,12,19,28H,11,13-14H2,(H,26,29)/t19-/m0/s1.
What are the key properties of 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide?
2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide has a molecular weight of 507.40 g/mol, XLogP of 4.12, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-chlorophenyl)-N-[(2S)-4-(4-chlorophenyl)sulfonyl-2-(hydroxymethyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetamide is sourced from PubChem (CID 69283020), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).